HomeSPRINT • STO
add
Sprint Bioscience AB
Previous close
kr 1.46
Day range
kr 1.38 - kr 1.48
Year range
kr 0.36 - kr 1.93
Market cap
155.11M SEK
Avg Volume
983.70K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 5.24M | -64.62% |
Operating expense | 11.83M | -11.86% |
Net income | -8.42M | -61.72% |
Net profit margin | -160.82 | -357.00% |
Earnings per share | — | — |
EBITDA | -8.13M | -61.05% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 10.95M | -65.48% |
Total assets | 21.44M | -53.42% |
Total liabilities | 15.37M | -52.76% |
Total equity | 6.06M | — |
Shares outstanding | 105.52M | — |
Price to book | 24.33 | — |
Return on assets | -69.94% | — |
Return on capital | -206.10% | — |
Cash Flow
Net change in cash
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -8.42M | -61.72% |
Cash from operations | -13.89M | -224.01% |
Cash from investing | — | — |
Cash from financing | 179.00K | — |
Net change in cash | -13.71M | -219.83% |
Free cash flow | -10.77M | -318.82% |
About
Founded
2009
Website
Employees
29
